Specific Cardiovascular Mortality in Cancer Survivors: A Nationwide Population‐Based Cohort Study in Japan
Patients with cancer had a higher CVD mortality risk, which was prominent in nonlymphoid hematologic malignancies. The mortality risk varied considerably by cancer type and specific CVD type.
Authors
- Ling Zha (ORCID: https://orcid.org/0000-0003-4668-4199)
- Tomohiro Kawano (ORCID: https://orcid.org/0000-0002-6282-4991)
- Isao Miyashiro (ORCID: https://orcid.org/0000-0002-2575-4971)
- Yasufumi Gon (ORCID: https://orcid.org/0000-0002-3907-1741)
- Hideki Mochizuki (ORCID: https://orcid.org/0000-0002-0874-7542)
- Haruka Kudo (ORCID: https://orcid.org/0000-0003-3816-8303)
- Tsutomu Sasaki (ORCID: https://orcid.org/0000-0001-8726-978X)
- Tomotaka Sobue (ORCID: https://orcid.org/0000-0003-2817-3483)
- Toshitaka Morishima (ORCID: https://orcid.org/0000-0002-0747-3287)
Institutions
- Osaka International Cancer Institute (JP)
- Osaka University Hospital (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1161/jaha.124.037965
- Citations
- 6
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 8.33